Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Increased temporal cortex CREB concentrations and antidepressant treatment in major depression.

Dowlatshahi D, MacQueen GM, Wang JF, Young LT.

Lancet. 1998 Nov 28;352(9142):1754-5. No abstract available.

PMID:
9848357
2.

Pro-apoptotic Par-4 and dopamine D2 receptor in temporal cortex in schizophrenia, bipolar disorder and major depression.

Glantz LA, Gilmore JH, Overstreet DH, Salimi K, Lieberman JA, Jarskog LF.

Schizophr Res. 2010 May;118(1-3):292-9. doi: 10.1016/j.schres.2009.12.027. Epub 2010 Jan 13.

3.

Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder.

Yamada S, Yamamoto M, Ozawa H, Riederer P, Saito T.

J Neural Transm (Vienna). 2003 Jun;110(6):671-80.

PMID:
12768362
4.
5.

Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia.

Uezato A, Meador-Woodruff JH, McCullumsmith RE.

Bipolar Disord. 2009 Nov;11(7):711-25. doi: 10.1111/j.1399-5618.2009.00752.x.

PMID:
19839996
7.
8.

Changes in CREB-phosphorylation during recovery from major depression.

Koch JM, Kell S, Hinze-Selch D, Aldenhoff JB.

J Psychiatr Res. 2002 Nov-Dec;36(6):369-75.

PMID:
12393305
9.

T-lymphocyte CREB as a potential biomarker of response to antidepressant drugs.

Lim SW, Kim S, Carroll BJ, Kim DK.

Int J Neuropsychopharmacol. 2013 Jun;16(5):967-74. doi: 10.1017/S1461145712001125. Epub 2012 Nov 20.

PMID:
23164431
10.
12.

Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia.

Yuan P, Zhou R, Wang Y, Li X, Li J, Chen G, Guitart X, Manji HK.

J Affect Disord. 2010 Jul;124(1-2):164-9. doi: 10.1016/j.jad.2009.10.017. Epub 2009 Nov 13.

14.

Alteration of cyclic-AMP response element binding protein in the postmortem brain of subjects with bipolar disorder and schizophrenia.

Ren X, Rizavi HS, Khan MA, Bhaumik R, Dwivedi Y, Pandey GN.

J Affect Disord. 2014 Jan;152-154:326-33. doi: 10.1016/j.jad.2013.09.033. Epub 2013 Oct 5.

15.

Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects.

Dwivedi Y, Rao JS, Rizavi HS, Kotowski J, Conley RR, Roberts RC, Tamminga CA, Pandey GN.

Arch Gen Psychiatry. 2003 Mar;60(3):273-82.

PMID:
12622660
17.

Alterations in phosphorylated cAMP response element-binding protein (pCREB) signaling: an endophenotype of lithium-responsive bipolar disorder?

Alda M, Shao L, Wang JF, Lopez de Lara C, Jaitovich-Groisman I, Lebel V, Sun X, Duffy A, Grof P, Rouleau GA, Turecki G, Young LT.

Bipolar Disord. 2013 Dec;15(8):824-31. doi: 10.1111/bdi.12131. Epub 2013 Nov 14.

PMID:
24238631
18.

Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication.

Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT.

Biol Psychiatry. 2001 Aug 15;50(4):260-5.

PMID:
11522260
19.

Alterations in cell adhesion molecule L1 and functionally related genes in major depression: a postmortem study.

Laifenfeld D, Karry R, Klein E, Ben-Shachar D.

Biol Psychiatry. 2005 Apr 1;57(7):716-25.

PMID:
15820228

Supplemental Content

Support Center